Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib

Detalles Bibliográficos
Autores principales: Alharbi, Musa, Mobark, Nahla Ali, Balbaid, Ali Abdullah O., Alanazi, Fatmah A., Aljabarat, Wael abdel Rahman, Bakhsh, Eman A., Ramkissoon, Shakti H., Abedalthagafi, Malak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446437/
https://www.ncbi.nlm.nih.gov/pubmed/32923892
http://dx.doi.org/10.1200/PO.20.00017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446437/
https://www.ncbi.nlm.nih.gov/pubmed/32923892
http://dx.doi.org/10.1200/PO.20.00017

Ejemplares similares